NCT06183047View on ClinicalTrials.gov

Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Early Release of Chromogranin A (CgA)
Interventions
DIAGNOSTIC_TEST

early release of chromogranin A (CgA) in patients with neuroendocrine tumours (NET) treated with peptide receptor radionuclide therapy (PRRT).

early release of chromogranin A (CgA) in patients with neuroendocrine tumours (NET) treated with peptide receptor radionuclide therapy (PRRT).

All Listed Sponsors
lead

Military Institute od Medicine National Research Institute

OTHER

NCT06183047 - Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT | Biotech Hunter | Biotech Hunter